NAT10 and neoplasm: The combination of remodelin and CTLA-4 mAb can further activate T cells and inhibite tumor progression.<h4>Conclusion</h4>Taken together, our study demonstrated that the NAT10-ac4C-JunB-LDHA pathway increases glycolysis levels and creates an immunosuppressive tumor microenvironment (TME).